Hello, this is Oliver Steil. Welcome. Thank you for joining. I have Stefan Gaiser with me, our CFO.
Hello.
Thanks for joining today. Today we would like to give you an update on a strategic acquisition that we've just signed, which we thought might be interesting for you. Sorry for the short notice of invitation, but that's how the things went during the day. We decided today that we acquire Ubimax, a German-based technology player, technology startup with some decent size already in the field of augmented reality, wearable IT at work, and also moving into IoT technologies. What they do, they have a solution which is called Frontline, which is effectively IT support based on wearables for frontline workers. This can be workers in production environments, in service environments, in logistics. Really clearly targeted towards certain verticals based on augmented reality and wearable IT, which we consider to be a very interesting field.
If you remember, in our discussions we had with you, we were talking a lot about our strategic growth areas based on our connectivity platform. We named particularly IoT and augmented reality and, of course, TeamViewer remote management and monitoring. Here we're now doubling down on the augmented reality/IoT space, which we consider to be very attractive. It's expanding our product offering very clearly. It allows us to provide solutions for even more use cases to our enterprise and medium-sized customers. There is a distinct new addressable market. If we look at the market studies and the quantification, our market quantified as going to be EUR 30 billion in 2023 based on the use cases that we have already been serving. Now we adding more use cases in the augmented reality field, which from the market studies that we know of is probably around another USD 10 billion or so.
It's a significant increase in our addressable market, and it's providing know-how, process know-how, software technology, and also solution delivery capabilities for the enterprises. We believe it's a very attractive play and a very attractive company, Ubimax, in this field. Clearly, they have been awarded certain prizes in the past. They clearly quoted by their customers as being the leaders in their field, very high productivity solutions. That we feel together with our offering, which is also high ROI and very scalable, as you know, we believe it's a great combination to build a joint technology leader in these fields coming out of Europe. I'd like to hand over to Stefan to talk a little bit about Ubimax and their customer base.
Yeah, let me give you some background on Ubimax and why we are so excited about this acquisition. It's really for us entering into a space which we consider an adjacent space. As you might know, we've entered that space with our Pilot product one and a half years ago, and pretty soon gained quite some traction around those augmented reality use cases. Ubimax is a fantastic expansion of those use cases. Where is Ubimax and how large is it? It was founded six years ago. It's based in Bremen, northern part of Germany, around 90 employees, LTM billings of around EUR 9 million, slightly cash negative, and operating in a market which is expected to be around EUR 20 billion in a couple of years. What do they offer?
Basically, they have a solution, a platform solution, which is called Ubimax Frontline, on top of which they have developed industry-specific solutions, which we're going to show you in a minute. They are led by a very strong management team, the three founders, who are, I would consider, real visionaries in the AR space and have really been influencing that space very significantly. All of them, all three of them will stay with us and will actually assume very senior management roles and really share our vision to create a German or European-based technology leader. I think we've been extremely impressed with our customer reference calls and the enterprise customers they have won. You can see the accounts, Schlumberger, DHL, John Deere, and the likes.
Very strong customer base, typical ticket size, EUR 50,000-EUR 100,000 or significantly north of that, with very substantial cross and upsell opportunity and super low churn. Very exciting customer use cases. Let's talk about that on the next slide, what they are offering. As I said, they have their Frontline platform, basically, upon which they released so far four different tailor-made solutions, xPick for supply chain, xMake for manufacturing and field service and remote support, xInspect and xAssist. I think what's quite common throughout those different products is that the productivity gain they provide are really substantial. If you take a look at Coca-Cola, for example, one of the key accounts of xPick, they have basically, due to the usage of xPick, achieved a picking accuracy of close to 100%.
You can imagine this is such a key process for a Coca-Cola bottling company and such a productivity increase and reduction of failures in the manufacturing process provides a super significant ROI for those customers. That's basically a very consistent theme throughout their larger customer base.
Maybe talking a little bit about the platform and how we think about the technology advancement that we're getting. On the next page, you see a picture of how we think about the global access network, the connectivity network, with the 1,100+ routers that sits underneath of it. We have the shared platform of common services that actually form the USP of TeamViewer, the IP around making connectivity happen all around the world between all the different devices. That, of course, is being used across all the different modules. As you know, we are trying to carve out certain modules for certain use cases, might be horizontal across industries, might be for certain industries.
Most prominent, of course, or very prominent in the last few months with COVID-19 was the remote access piece, for to work from home, the meeting piece, video where we had some extra demand, but of course, also monitoring. The Pilot in the augmented reality space and the IoT space. Ubimax, in that sense, is providing more use cases, more solution modules, as Stefan just mentioned, xPick, xInspect and so forth, which will then sit on our platform, which will allow customers to buy the connectivity for all their devices. On top of that, a module to drive workforce efficiency, in the respective spheres. Also the IT remote management, which we already have and work from home, all under the Tensor umbrella brand at some point where we allow for managed connectivity, conditional access, very high security. This is the vision.
Additional use cases, additional solutions on the back of our global connectivity platform. That's where we share the joint vision with the Ubimax team that their process know-how, their industry knowledge, their data analytic capabilities in their respective fields can be married with our horizontal platform, easy-to-use platform, and that will give them more scalability and us more vertical knowledge and a broader solution portfolio.
On the next slide, the strategic rationale, I think this is really a transaction which ticks all of the boxes for us. I think we talked to many of you about what kind of acquisitions we would consider, and this really ticks all the boxes. We always said we would be looking into technology acquisitions, and that's clearly one. It provides us our entry into a significantly larger TAM. We acquire the global market leader for AR-based enterprise wearable solutions. All customer reference calls clearly confirm that this is the company to go for in that space, resulting in a significant TAM expansion, as we just explained. I think we've been impressed by the business critical know-how they developed over the last few years due to their very tight integration into the processes of the customers, the very tight workflow integration.
This results in a very high customer stickiness, as I said, super low churn and very high net retention rate. That's why we see a significant cross and upsell potential. We can obviously sell their product or their platform into our large enterprise client base. At the same time, they have a blue-chip customer base where we can obviously up and cross-sell our existing TeamViewer product portfolio. Very exciting is also their future innovation, especially around data-driven workflow solutions. Think about all of the knowledge they gain, how to improve business processes in logistics, in production environments, and how you can share that with other customers, and really, provide even more added value going forward. Financially, they've been close to breakeven the last couple of quarters. They should be profitable for the remainder of the year, although barely profitable.
They have a high net retention rate of more than 140%, are clearly growing above market growth. As I said, we believe we have found a very strong and experienced management team who shares our vision and who will become a key part of our senior leadership team. Let's talk about next slide, or go to next slide, where you again see just in a summary, the benefits of this acquisition. It results in a TAM expansion. We will realize go-to-market synergies. We can address and access an enlarged enterprise customer base. We will integrate their products into our TeamViewer platform. It gives us, finally, another verticalized product, similar with our IoT product and remote management. This is yet another verticalized product on top of our platform. On the right-hand side, you can see the Ubimax billing split for 2019.
It's a pure subscription business with additional professional services and implementation services. They need some implementation services together with the customer to integrate into their back-end systems like an SAP or Oracle. More than 50% of their billings are subscription billings. They nearly doubled in 2019, we expect them to double again in 2020. Obviously they should grow significantly faster or faster than TeamViewer because they operate in a market which is growing faster. We'd expect them to grow 45%-50% CAGR under the next few years. Maybe to wrap it up, transaction highlights, valuation, we pay on a cash and debt-free basis, EUR 136.5 million. This represents a multiple of slightly north of 12 times on a 2020 billings basis and below 10 times on 2021. I think overall, a very reasonable valuation.
Clearly, the company is young, but has already gained quite some market reputation. It's a very strong customer base and shows significant acceleration in their subscription billings. How do we pay that? EUR 85 million will be taken from cash from the balance sheet, basically. We pay roughly 60% in cash. We can easily or comfortably finance that from the existing cash position and EUR 50 million or EUR 50.7 million will be paid by issuing 1,070,000 shares from the existing authorized capital with subscription rights excluded. Management retention, very keen to have the team on board. The Ubimax founders are locked in for the long term. They will assume key management positions. They also get a lockup for their share consideration up to three years with yearly vesting, and they will also participate in TeamViewer long-term incentive plan.
Timing on this transaction, we expect closing to occur sometimes in Q3, probably towards the end of Q3, which means we consolidate their results fully, probably starting Q4 2020.
Yeah. I think clearly from our perspective, we are very excited with this transaction. It's very important for us to find a company, or was important to find a company that is bringing us great technology, strong customer traction, where there's a good cultural fit. I think you know that the TeamViewer culture is very special. People are very entrepreneurial and driven, and have been very eager to generate growth and innovate. We found we should look into companies that bring the same, and we're convinced that Ubimax does so because it has been gaining awards, it's very positively discussed by media and by customers. Therefore, we believe they are really subject matter experts in their field, and that will accelerate our development in this. We're very happy that the management team will engage, which is of course key to success going forward.
We believe the price is fair, the size of the transaction makes sense, and the cultural dimension should actually work out very well. We're very positive with this and we believe that we have significantly strengthened our solution delivery and solution development capability in certain enterprise verticals, which is clearly one of our strategic goals and will lead to a TAM expansion. I think with this, we'll probably open the floor for any kind of questions that you might have.
The first question is from Stacy Pollard, J.P. Morgan. Your line is now open. Please go ahead.
Oh, thank you very much. A few questions from me. First of all, what happens to your Pilot product? Is there overlap or does Ubimax sort of replace it? Will you run Ubimax sort of independently or will you properly integrate them together? Second question, profitability. Now, I'm assuming fairly low, but is it a big negative number? What kind of profitability would you expect from the Ubimax business in, say, the midterm, so I don't know, 2 or 3 years down the road, given that it's an enterprise business, could we expect the same kind of economies of scale or margins that you're getting in your core TeamViewer, or is that something we need to adjust?
Yeah. Thank you for your question. On Pilot, we will definitely continue with the Pilot product. Whether it will be the same name over time, that remains to be seen. Pilot comes with a very strong functionality, which is instant connectivity on tablets, mobile phones, across all the major operating systems. Very much carrying the TeamViewer USP, and that will continue. On top of that connectivity, Ubimax will bring additional business process solutions for digitizing enterprises. Our view is that we will integrate these two into a AR/IoT product suite. When we talk about integration, like you say, we will talk about proper integration. We've clearly laid out a plan over time to make it an integrated solution stack. Anyway, also from an organizational perspective, we will work as one leadership team over time, and run the business as one leadership team.
We're really big fans of single culture integration, and we will do the utmost to integrate it properly.
Maybe from an economics perspective or financial model perspective, I think we very consistently said that we would sacrifice some margin for longer or faster top-line growth, and I think Ubimax provides exactly that. They've been nearly doubling their billings the last year, and despite that fast growth and unlike many other technology peers, they've actually been close to breakeven. If you actually add the billings growth and free cash flows, it's close to 100, and from that perspective, doesn't really dilute our combined top-line and margin profile. I think that that's important for us. Clearly, it will be somewhat dilutive, probably not so much in this year, but with the full consolidation contribution in the next fiscal year, it will be somewhat dilutive on our EBITDA margins.
We've closely examined their go-to market model and the customer relationship and the customer lifetime value of their customer is extremely strong. I would certainly expect that they will become a very profitable business. Whether they're quite gonna achieve TeamViewer's margin, that's probably tough, yeah, given that we have a very unique business model. Yeah. I'm certain that they can achieve a very decent profitability. Again, the combination of top-line growth and margin really ticks all boxes for us and will not be dilutive for us.
One thing we're really good at, or have been good at at TeamViewer over the last 15 years, is somewhat distilling the solution for different customers and different industries to a productized, scalable software as a service model. I think many of the kind of technology startups are in a phase where they have very good pilot installations, so pilot meaning proof of concept. They have a mix of consulting, hardware, and software as a service. They kind of are on the verge to productize and scale their solutions such that they can reap the economics that get close to our economics. Now I think by combining these two businesses, I think we bring this knowledge to a company that is just about to have a significant share of software as a service.
They're coming out of this, call it proof of concept, pilot phasing more and more. We believe it's a very good moment in time. On top of that, we will bring all our knowledge to scale, go to market, to productize the offering, to make it as horizontal as possible while maintaining the industry-specific knowledge that is needed. I think that can be a very winning recipe for profitability for both businesses going forward.
Thank you.
The next question is from Mohammed Moawalla of Goldman Sachs. Your line is now open. Please go ahead.
Great. Thank you. Hi, Oliver. Hi, Stefan. Just a couple from me. Maybe could you talk a bit more about the sort of cross-sell, up-sell synergies, how much kind of customer overlap you have, and where is the kind of complementary aspect of the customer base that Ubimax brings? How big of a driver will this be towards driving that and driving more enterprise penetration? In terms of, one of the things you've talked about is deal size is kind of increasing in IoT. Secondly, on the growth, right now it's sort of roughly the revenue mix is 50/50 between subscription and then hardware and services. I think on slide eight, you talk about that mix shifting considerably to kind of 80% subscription. How is that going to happen?
Are you going to look to farm out the hardware to others, or is it simply the subscription line grows even sort of faster than the overall billings?
Yeah. I think cross-sell, up-sell, where the complementarity is really TeamViewer Tensor, which you know very well, and where we've shown the deal sizes above EUR 1 million and also the top 50 deals. TeamViewer Tensor is allowing for managed connectivity. Once we're in a customer with that managed connectivity, we are really trying to sell additional use cases, that can be remote management of IT, that can be meeting, that can be work from home, and it can be the whole field of augmented reality where we have Pilot at the moment. That's the complementarity where we can combine the connectivity that our platform brings with industry-specific solution in an end-to-end one-stop-shop, so to say. A bit of integration needed, that's clear and that's always the case. We will have very complementary offerings, and to be able to serve larger organizations.
From a customer base, if you look through the logos that Ubimax have, large organizations, mostly large organization enterprise, that's also the area where we want to grow. The customer overlap is probably high, but we might be in a very small ticket, which is also what we always talked about. We are present in most organizations, in most markets anyway, but to a smaller extent, and then we try to expand. Now we come from the one side, might be small ticket today, connectivity. Ubimax comes from the other side, business critical solution, bigger ticket size. I think there's a natural way of combining that and growing into the large enterprise with deal sizes, as Stefan mentioned, EUR 50K, EUR 100K, EUR 150K. A tilt, I would say, towards the higher end of the TeamViewer deal size.
We are going to develop into this and we are developing, as you know, biggest customer well above EUR 500,000 now, more and more regularly, six-digit deals. That's already what is regular in Ubimax on a smaller scale. That will allow us to have a better solution portfolio for large enterprises. I think there will be an element of scaling down their solution and productizing it, and using our significant subscriber base of 500,000 subscribers, and sell productized part of their solutions into these subscribers.
Then maybe from the billing base perspective, Mo, I think what we've clearly experienced is that once Ubimax lends to the customer and actually has a chance to show their value add, those customers are very sticky and buy and roll out the product on a significantly larger basis. DHL is a point in case. I think they started off with less than 100,000, are significantly more than that in the meantime, because they roll it out across their sites, they roll it out actually because the product is now productized in such a way that any new site can be deployed with very little professional services. That will actually reside in a significant tilt towards more subscription billings contribution and less professional services. On the hardware piece, that's clearly not strategic.
I think in the past, they just basically sold it to make it easier for the customer, but that's not a strategic part of the business plan. Those are the reasons why this business will become an 80% subscription billings business.
Great. Maybe if I can squeeze one in. On Q2, it seemed like that kind of developed to expectations. You talked about that normalization of demand. I know you alluded to that in the month of April. Are we seeing much more of a steady flow in terms of the kind of billings growth on the kind of core now based on what you've seen on Q2?
Yeah, I think that's a good summary, Mo. Indeed, I think exactly as you said, April very strong. May and June, the expected normalization. July started well. That's exactly what we've been seeing.
Okay. Thank you.
Of course. One thing I'd like to add on Q2, we should, of course, not forget that we, in most or many markets, in many countries, we still have COVID-19 significantly. U.S., I think we don't need to discuss how the situation is there.
I think Q2 we have to see in light of the Corona effect on enterprise deals, where there's certainly in some markets, I guess, some hesitation to procure. The effect that we have said that while Corona is on in markets, we don't do any free to paid monetization. We have completely abstained from that in most markets, except China, which I think we discussed. These two factors together, coming out of that quarter with this result that you see in here, makes us very happy.
Okay. Thank you very much.
The next question is from Gustav Froberg, Berenberg. Your line is now open. Please go ahead.
Hi, everyone. Thank you for taking my questions. I have just a couple as well. Firstly, just on the integration timeline. I know you talked about the deal closing in Q3, you expect. In terms of integrating the sort of Ubimax platform, if you will, or Ubimax software stack onto your own, how long do you expect that to take, and how much work do you envisage that that will be for you?
Integration timeline overall, I think if we look at it into three phases, there will be quite some joint go-to-market communication early on. The second phase will clearly be about cross-sell enablement for the different sales forces in the kind of mid-market, but also enterprise sales forces. Of course, there will also be integration work in the back end on CRM systems, digital assets and the like. Overall timeline, we've given ourselves one year to get it fully done. The main focus, of course, will be the first three to six months where we talk about go-to-market synergies in solution development and then platform questions. There are a few over time that might take a bit longer until there's full integration.
I think we should give us enough time on this one because there's so much we can do on the customer side already, and we should really try to reap these benefits soon.
All right. Super.
As for joint work, how do we assess that? We don't consider it to be a big integration. Ubimax has an organization of 90 people, very R&D driven, like we at TeamViewer are. We'll integrate the R&D teams that deal with augmented reality. We have the different sales forces in different countries. I wouldn't consider that to be a terribly difficult integration.
All right, super. Just on kind of the outlook for M&A, I guess, as well. Are you happy with the M&A situation right now, or could you see yourself doing more deals this year, or is this sort of it for now?
I wouldn't say it's sort of it for this year, clearly now we focus on Ubimax and getting started jointly, frankly. I think what we learned over the last couple of months as part of this exercise is that there are many exciting technologies out there which would fit into our longer-term vision, I would say. Yeah. I think we start with an acquisition which ticks really all of the boxes for us. Fantastic technology, strong customer base, strong entrepreneurial culture, not too big, but also not too small. I think it's really good for us to train our M&A muscle. Maybe there's something more coming this year or not, can't really tell. Yeah.
Okay, fine. Just the final one on Q2 as well, I wanted to sneak in a question. Just in terms of the number there, could you give us any indication on the split between new billings versus renewals?
We provide that update really with our Q2 results early August, but I wouldn't expect any major changes there.
All right. Super. Thank you.
It's a strong quarter.
The next question is from George Webb, Morgan Stanley. Your line is now open. Please go ahead.
Good afternoon, Stefan and Oliver. A couple of questions from me, please. Firstly, on the Ubimax acquisition, can you talk a little bit more about the go-to-market model they have and what a typical sales timeline is for them from first discussion with a customer through to that then being used in actual workflows? Secondly, you've mentioned turning off the monetization engine. How do you think about the timeline for turning that back on in most markets through the rest of this year? Also, if there's anything you can give us in terms of what impact that had in your second quarter, that'd be very helpful as well. Thank you.
Ubimax go-to-market is enterprise sales, clearly direct sales force and working with partners, partly integration partners, distribution partners, but mostly it's really direct touch. Very comparable to our newly built enterprise sales force that we started one and a half years ago. Sales cycle, I think the way they describe it is like two different sales cycles. If you really look at a very first proof of concept installation of their solution until the first full license, I think with all the deployment and all the work around it, from what I learned, Stefan talked to customers, but that can easily be six to 12 months.
Correct.
It takes a while, clearly, because it's mission critical. Where they are at the moment is that in many of their existing customers, they have gone beyond that stage of proof of concept. They are embedded now, and customers have made it a solution which is then rolled out by manufacturing plant, by bottling facility, by warehouse, by repair center. Of course, this is then upsell, where the sales cycles are significantly shorter, and we talk more three to six months. Which I think overall is also, again, quite comparable to what we see in our case. Very fresh digitalization projects take long, upsell opportunities, cross-sell opportunities are faster. Of course, there's an overlay of COVID now, which we all need to understand, especially in the U.S. over the next quarters or so, but so far, all good.
Free to paid, not sure I got your question. Fully right, we've not used it at all, forced free to paid in the first 2 quarters, except for a few tests in China in Q2. Very marginal contribution there, however, because we're also focusing on other things in China. I think the straight answer is in Q2, forced free to paid was zero.
Maybe just on that, can you give us any color in terms of how much of a headwind that actually was then in terms of your growth in Q2?
Look, that's hard to quantify because I think as we discussed in the past, we do these campaigns when we feel the free user ecosystem is in a good place. We feel that in a certain market, we should run campaigns, try them, test them, refine them. There's always some activity there. In the past, historically, very rough cut, the forced free to paid contributions per year was around EUR 20 million in billings or so. We have not realized almost anything in the first two quarters. Naturally, first quarter, we were swamped by demand. Second quarter, very sensitive situation. We haven't realized anything of that. Now, having said that, I wouldn't suggest that now the second two quarters, there is an extra EUR 20 million flowing in from that because markets are still in difficult phases.
Some markets are done for the moment with COVID, I would say. Some other markets are in deep trouble, especially the U.S., a big market for us, our biggest market. Everybody's wary of the second wave and so on. We will make steps left, right, center, try out things, and see what the result is. In the next two quarters, I would assume there is a contribution. We can't tell you now how big it will be. We will, of course, like always, put more light on this, the more we learn as we go along.
Thank you.
There are currently no further questions. As a reminder, if you would like to ask a question, please press zero and one on your telephone keypad now. The next question is from Ben Castillo-Bernaus, Barclays. Your line is now open. Please go ahead.
Good afternoon. Thank you for taking my question. I just have a quick one on the outlook. You clearly had another strong quarter, and you mentioned July started well. There's clearly upside pressure building to the full year guidance. Have you considered upgrading it? Or maybe what is holding you back?
Well, I think today we really want to speak about the Ubimax acquisition because that kept us pretty busy the last few weeks, if I may say so. I think we provide full guidance and full year outlook when we announce our Q2 results early August. I think that's a better time then to address those questions. We also have a better feeling of how July shapes out. It's early days in July still, but by then we have more than a third of the quarter already under our belt and can probably better forecast the remainder of the year.
Yeah, please bear with us on this one. Normally we would be in week two of a new quarter. We have fully analyzed the previous one, and we have a good sense of how we started. Frankly, it's all been overcast a little bit at the moment, by us being busy in the last two weeks, 10 days with this transaction. We need to form a view and see also how some markets behave over the next two weeks, and then I think beginning of August, we can give you a better view on this one.
Okay, fair enough. Thank you.
We do not have any further questions at this point. I hand back to the speakers.
Yeah. Thank you very much for your questions.
Thank you.
For interest, we're going to talk again soon, I guess, beginning of August. Yeah, all the best.
Thank you.
Stay healthy.
Thanks.